Hypera Pharma S.A.
HYPE3 · B3 - Brasil, Bolsa, Balcão (BVMF) · Health Care
About the company
Hypera Pharma is Brazil's largest pharmaceutical company by revenue in the branded drugs and over-the-counter (OTC) segment, with a portfolio of more than 200 prescription and non-prescription products across several therapeutic categories. The company's brands include Buscopan, Engov, Benegrip, Tandrilax, and Addera. Hypera focuses on high-margin, prescription-to-OTC switch products and actively acquires established pharmaceutical brands.
| Exchange | B3 - Brasil, Bolsa, Balcão (BVMF) |
| Ticker | HYPE3 |
| Sector | Health Care |
| Indicative market cap USD | $3.50B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
On its home market (B3 - Brasil, Bolsa, Balcão (BVMF)), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- B3 – Brasil, Bolsa, Balcão — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Brazil
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.